| Sign In to gain access to subscriptions and/or personal tools. |
Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in manMedical School Hannover (Germany), Department of Clinical Psychiatry and Psychotherapy, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany; dr.passie{at}gmx.de
Department of Anaesthesiology,Medical School Hannover, Hannover, Germany
Department of Clinical Psychiatry and Psychotherapy, Medical School Hannover, Hannover, Germany
Department of Biometry, Medical School Hannover, Hannover, Germany
Department of Clinical Psychiatry and Psychotherapy, Medical School Hannover, Hannover, Germany The role of the N-methyl-D-aspartate (NMDA) neurotransmitter system in relation to psychoses is not completely understood, but represent a challenge in neurobiological research. The psychotic states induced by NMDA antagonists such as phencyclidine and ketamine have been described as being most similar to schizophrenia and the NMDA system has been implicated in the pathogenesis of schizophrenia. Binocular depth inversion, an illusion of visual perception, has been shown to be impaired in psychotic and psychotomimetic states in healthy and schizophrenic subjects. In this study, pictures of natural and artificial objects were presented stereoscopically to 12 healthy male volunteers and depth perception assessed using an operationalized method. The effects of the psychotomimetic S-enantiomer of the anaesthetic ketamine in two different subanaesthetic doses were compared with those of a placebo. In spite of dose dependence and grave subjective and significant objective psychopathology, no significant impairment of binocular depth perception was found with (S)-ketamine. Implications related to memory function, perceptogenesis and bottom-up processing in ketamine model psychosis and schizophrenia are discussed.
Key Words: altered states of consciousness binocular depth inversion hallucinogens memory model psychosis NMDA receptors psychopathology schizophrenia (S)-ketamine
Journal of Psychopharmacology, Vol. 17, No. 1,
51-56 (2003) |
|||